Ilgiz Gareev

1.9k total citations
112 papers, 1.3k citations indexed

About

Ilgiz Gareev is a scholar working on Molecular Biology, Cancer Research and Neurology. According to data from OpenAlex, Ilgiz Gareev has authored 112 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 57 papers in Molecular Biology, 57 papers in Cancer Research and 22 papers in Neurology. Recurrent topics in Ilgiz Gareev's work include MicroRNA in disease regulation (43 papers), Circular RNAs in diseases (34 papers) and Cancer-related molecular mechanisms research (33 papers). Ilgiz Gareev is often cited by papers focused on MicroRNA in disease regulation (43 papers), Circular RNAs in diseases (34 papers) and Cancer-related molecular mechanisms research (33 papers). Ilgiz Gareev collaborates with scholars based in Russia, China and Qatar. Ilgiz Gareev's co-authors include Ozal Beylerli, Guang Yang, Tatiana Ilyasova, В. Н. Павлов, Albert Sufianov, Shiguang Zhao, Aamir Ahmad, Gjumrakch Aliev, Aferin Beilerli and А. А. Измайлов and has published in prestigious journals such as SHILAP Revista de lepidopterología, International Journal of Molecular Sciences and Journal of neurosurgery.

In The Last Decade

Ilgiz Gareev

102 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ilgiz Gareev Russia 23 762 676 159 97 94 112 1.3k
Ozal Beylerli Russia 24 892 1.2× 803 1.2× 117 0.7× 82 0.8× 92 1.0× 109 1.5k
Fan Zhao China 16 323 0.4× 159 0.2× 156 1.0× 92 0.9× 85 0.9× 77 797
Eva Hamade Lebanon 19 532 0.7× 331 0.5× 44 0.3× 77 0.8× 159 1.7× 50 1.2k
Tsu‐Hsiang Lu Taiwan 19 494 0.6× 318 0.5× 40 0.3× 79 0.8× 104 1.1× 39 850
Hanyu Wang China 19 514 0.7× 258 0.4× 45 0.3× 80 0.8× 58 0.6× 73 1.1k
Shiguang Zhao China 22 386 0.5× 198 0.3× 306 1.9× 151 1.6× 37 0.4× 46 1.1k
Yuehong Li China 19 500 0.7× 227 0.3× 44 0.3× 73 0.8× 98 1.0× 98 1.2k
Nader Akbari Dilmaghani Iran 13 300 0.4× 245 0.4× 129 0.8× 73 0.8× 20 0.2× 56 767
Laura Graciotti Italy 17 498 0.7× 231 0.3× 34 0.2× 76 0.8× 130 1.4× 39 961
Nicolas Magné France 14 268 0.4× 172 0.3× 90 0.6× 60 0.6× 88 0.9× 49 826

Countries citing papers authored by Ilgiz Gareev

Since Specialization
Citations

This map shows the geographic impact of Ilgiz Gareev's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ilgiz Gareev with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ilgiz Gareev more than expected).

Fields of papers citing papers by Ilgiz Gareev

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ilgiz Gareev. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ilgiz Gareev. The network helps show where Ilgiz Gareev may publish in the future.

Co-authorship network of co-authors of Ilgiz Gareev

This figure shows the co-authorship network connecting the top 25 collaborators of Ilgiz Gareev. A scholar is included among the top collaborators of Ilgiz Gareev based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ilgiz Gareev. Ilgiz Gareev is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gareev, Ilgiz, Ozal Beylerli, Albert Sufianov, В. Н. Павлов, & Huaizhang Shi. (2025). Stromal vascular fraction cell therapy: A promising therapeutic method for intracerebral hemorrhage. 6(3). 110–120. 2 indexed citations
3.
Gareev, Ilgiz, et al.. (2024). New frontiers in scar management: Adipose tissue transplantation techniques. SHILAP Revista de lepidopterología. 6(4). 206–213. 1 indexed citations
4.
Gareev, Ilgiz, Aamir Ahmad, Tatiana Ilyasova, et al.. (2024). Comparative Analysis of Circular RNAs Expression and Function between Aortic and Intracranial Aneurysms. Current Drug Targets. 25(13). 866–884. 1 indexed citations
5.
Gareev, Ilgiz, Ozal Beylerli, Tatiana Ilyasova, et al.. (2024). Therapeutic application of adipose-derived stromal vascular fraction in myocardial infarction. iScience. 27(5). 109791–109791. 10 indexed citations
6.
Gareev, Ilgiz, Ozal Beylerli, & Boxian Zhao. (2024). MiRNAs as potential therapeutic targets and biomarkers for non-traumatic intracerebral hemorrhage. Biomarker Research. 12(1). 17–17. 10 indexed citations
7.
Gareev, Ilgiz, et al.. (2024). Surgical Treatment of Primary Spinal Tumors. SHILAP Revista de lepidopterología. 14(3). 243–254.
8.
Usman, Muhammad Andry, Aferin Beilerli, Albert Sufianov, et al.. (2023). Investigations into the impact of non-coding RNA on the sensitivity of gastric cancer to radiotherapy. Frontiers in Physiology. 14. 1149821–1149821. 2 indexed citations
9.
Gareev, Ilgiz, Aamir Ahmad, Jiaqi Wang, et al.. (2023). Gastric juice non-coding RNAs as potential biomarkers for gastric cancer. Frontiers in Physiology. 14. 1179582–1179582. 7 indexed citations
10.
Keskin, Cumali, Ayşe Baran, Mehmet Fırat Baran, et al.. (2023). Green synthesis of silver nanoparticles mediated Diospyros kaki L. (Persimmon): determination of chemical composition and evaluation of their antimicrobials and anticancer activities. Frontiers in Chemistry. 11. 1187808–1187808. 25 indexed citations
12.
Beylerli, Ozal, Jiaming Ju, Aferin Beilerli, et al.. (2023). The roles of long noncoding RNAs in atrial fibrillation. Non-coding RNA Research. 8(4). 542–549. 2 indexed citations
13.
Gilyazova, I. R., Elizaveta Ivanova, Mikhail Y. Sinelnikov, et al.. (2022). The potential of miR-153 as aggressive prostate cancer biomarker. Non-coding RNA Research. 8(1). 53–59. 6 indexed citations
14.
Маслов, Л. Н., С. В. Попов, А. V. Mukhomedzyanov, et al.. (2022). Pharmacological Approaches to Limit Ischemic and Reperfusion Injuries of the Heart: Analysis of Experimental and Clinical Data on P2Y12 Receptor Antagonists. Korean Circulation Journal. 52(10). 737–737. 3 indexed citations
15.
Gareev, Ilgiz, Chao Yuan, Yanchao Liang, et al.. (2022). The Mechanisms of Current Platinum Anticancer Drug Resistance in the Glioma. Current Pharmaceutical Design. 28(23). 1863–1869. 11 indexed citations
16.
Gareev, Ilgiz, et al.. (2021). Long non-coding RNAs in oncourology. Non-coding RNA Research. 6(3). 139–145. 30 indexed citations
17.
Beylerli, Ozal, et al.. (2021). Differential non-coding RNAs expression profiles of invasive and non-invasive pituitary adenomas. Non-coding RNA Research. 6(3). 115–122. 35 indexed citations
18.
Yang, Guang, Lu Wang, Jingxian Sun, et al.. (2020). Left ventricular ejection fraction as an independent predictor of poor outcome in acute intracerebral hemorrhage. Brain and Behavior. 10(7). e01643–e01643. 4 indexed citations
19.
Shi, Huaizhang, Guang Yang, Cheng Gao, et al.. (2020). Management of Neurosurgical Patients During the COVID-19 Pandemic. SHILAP Revista de lepidopterología. 10(3). 177–182. 2 indexed citations
20.
Liu, Zhendong, Ruotian Zhang, Tao Yan, et al.. (2019). Identification of hub genes and small-molecule compounds related to intracerebral hemorrhage with bioinformatics analysis. PeerJ. 7. e7782–e7782. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026